Authors of a study presented at the 2019 ACR/ARP Annual Meeting sought to better understand the effects of denosumab discontinuation in patients with rheumatoid arthritis who received treatment with...
Authors of a new study presented at the 2019 ACR/ARP Annual Meeting evaluated the safety and efficacy of immune checkpoint inhibitor therapy in patients with preexisting autoimmune diseases.
Authors of a new study presented at the 2019 ACR/ARP Annual Meeting evaluated the safety and efficacy of immune checkpoint inhibitor therapy in patients with preexisting autoimmune diseases.
The authors evaluated whether polypharmacy is associated with treatment response and serious adverse events among more than 22,000 patients with rheumatoid arthritis.
The authors evaluated whether polypharmacy is associated with treatment response and serious adverse events among more than 22,000 patients with rheumatoid arthritis.
By analyzing previous studies, authors of a new review determined whether a vegetarian or vegan diet could be a cost-effective way to manage RA symptoms, including inflammation and joint pain.
Researchers randomly assigned more than 400 individuals with rheumatoid arthritis to placebo or a new selective janus kinase 1 inhibitor to determine efficacy in improving symptoms of rheumatoid arthritis.
...
Researchers randomly assigned more than 400 individuals with rheumatoid arthritis to placebo or a new selective janus kinase 1 inhibitor to determine efficacy in improving symptoms of rheumatoid arthritis.
...
The authors of a new study assessed the relationship between atherosclerosis risk and rheumatoid arthritis remission among more than 700 individuals. The findings were presented at EULAR 2019.
The authors of a new study assessed the relationship between atherosclerosis risk and rheumatoid arthritis remission among more than 700 individuals. The findings were presented at EULAR 2019.
